St Louis American reports

Sen. Joseph Keaveny, D-St. Louis, presented Senate Bill 822 to the Senate Veterans’ Affairs and Health Committee regarding Cannabidiol (CBD) oil on Thursday, February 25.

“This legislation can help thousands of people across our state who battle against the symptoms of their illnesses daily,” Sen. Keaveny said. “I am hopeful this legislation will make its way to the governor’s desk.”

CBD oil is extracted from the cannabis or marijuana plant. It is not the chemical substance in marijuana known as THC, which causes users to get high or intoxicated.

Senate Bill 822 would allow people with cancer, HIV, AIDS, amyotrophic lateral sclerosis, Parkinson’s disease, multiple sclerosis, spinal cord damage, inflammatory bowel disease, neuropathies, Huntington’s disease, post-traumatic stress disorder, or certain specified symptoms or complications associated with the conditions listed above, to have access to CBD oil. The oil must be recommended by a neurologist or a physician. The Department of Health and Senior Services would establish a public registry of physicians and neurologists who recommend hemp extract for their patient’s use.

“Missouri has the potential to expand an industry that will create hundreds of jobs. CBD oil has been shown to reduce nausea and vomiting, suppress seizure activity, and combat inflammatory disorders, neurodegenerative disorders, tumor and cancer cells, and anxiety and depression disorders,” Keaveny said. “Research has shown that CBD inhibits the proliferation of cancer cells, and has found that CBD can be used to treat rheumatoid arthritis, autoimmune diseases, nausea, bowl disorders and diabetes.”

For more information, visit Sen. Keaveny’s official Senate website at

Article At

Bill History At Legiscan